Evidence map›Paper›PMID 40905853›Full record

Trial reportInternational journal of surgery (London, England)2026

Transcutaneous auricular vagal nerve stimulation improves functional dyspepsia with sleep disturbance via enhanced vagal activity: a randomized controlled trial.

Jingyao Li, Lianli Wang, Yue Zhang, Ruiting Meng, Boxu Zhu, Jiande D Z Chen, Fei Dai

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in International journal of surgery (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jingyao LiDivision of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Lianli WangDivision of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Yue ZhangDivision of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Ruiting MengDivision of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Boxu ZhuDivision of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Jiande D Z ChenDivision of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan, USA.
Fei DaiDivision of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.ORCID 0000-0001-8992-3079

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFunctional dyspepsia (FD) is often comorbid with sleep disturbance. Transcutaneous auricular vagal nerve stimulation (taVNS) is a new and non-invasive therapeutic option. This study aimed to investigate its effects and possible mechanisms on FD with sleep disturbance.

methodsThis was a prospective, single-center, single-blind, and randomized controlled trial. Fifty-four FD patients with sleep disturbance were randomly divided to receive 4-week taVNS or transcutaneous non-vagal nerve stimulation (tnVNS). The primary outcomes included Nepean Dyspepsia Index Symptom (NDIS) and Pittsburgh Sleep Quality Index (PSQI). The secondary outcomes were composed of Nepean Dyspepsia Index Quality of Life (NDIQOL), Hamilton Anxiety (HAMA), Depression (HAMD), autonomic functions, gastric slow waves, gastric accommodation, and serum melatonin.

resultsCompared with tnVNS: (1) taVNS resulted in a lower NDIS and PSQI scores ( P < 0.05); it also reduced HAMD and HAMA scores but increased NDIQOL score ( P < 0.05). (2) taVNS increased the percentage of normal gastric slow waves (NSW%), the maximum tolerable volume, the serum melatonin level, and the high-frequency (HF, reflecting vagal activity) component in the fasting state ( P < 0.05). In taVNS group, the HF in the fasting state was positively correlated with the NSW% and the melatonin level.

conclusiontaVNS is effective and safe for the treatment of FD with sleep disturbance. The effect may be attributed to the dual neuromodulating effects of taVNS on both the gut and the brain via enhanced vagal activity.

Indexed as

DyspepsiaSleep Wake DisordersTranscutaneous Electric Nerve StimulationVagus Nerve StimulationAdultFemaleHumansMaleMiddle AgedProspective StudiesQuality of LifeSingle-Blind MethodTreatment OutcomeVagus Nervefunctional dyspepsianeuromodulationrandomized controlled trialsleep disturbancetranscutaneous auricular vagal nerve stimulationvagal activity

Identifiers

PMID40905853
PMCPMC12825726

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.